Breast Cancer-Related Lymphedema & Management: Modern Risk Assessment, Surveillance & Care P
Hear Dr. Jason Edwards share his experience distilling recommendations from clinical literature to guide everyday clinical practice for breast cancer-related lymphedema pathways.
Watch other webinars at https://tactilemedical.com/education
00:00 – Intro
2:15 – The scope and burden of breast-cancer related lymphedema
6:26 – Mechanisms of lymphatic damage during cancer treatment
9:00 – Why early stage lymphedema intervention matters
13:26 – Creating a system for lymphedema surveillance
15:18 – Predictive risk for developing breast cancer-related lymphedema
17:05 – Using patient reported symptoms to diagnose lymphedema
18:41 – Breast or truncal edema after breast cancer treatment
21:24 – Pillars of lymphedema management
23:21 – My practice for lymphedema referral pathway
24:44 – Tools for lymphedema self-management
26:37 – Using Flexitouch for cancer-related lymphedema home treatment
28:15 – Flexitouch is more effective than self-MLD with high patient satisfaction
29:41 – Flexitouch improves lymphedema outcomes and reduces costs
30:20 – My personal clinical experience with lymphedema
31:45 – Q&A with the audience
33:52 – Do you ever refer for surgical interventions for BCRL?
35:28 – What is the role of a radiation oncologist in lymphedema management?
37:01 – At what point do you consider edema to be lymphedema?
42:21 – Can we prevent or cure lymphedema with early intervention?
44:48 – Do you incorporate static compression for truncal treatment?
-
Category
No comments found